Literature DB >> 17021671

Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan.

Chun-Hsiung Chen1, Kuan-Chia Lin, Horng-An Chen, Hsien-Tzung Liao, Toong-Hua Liang, Hon-Pin Wang, Chung-Tei Chou.   

Abstract

Acute anterior uveitis (AAU) is the most frequently extra-articular manifestation of ankylosing spondylitis (AS). To investigate whether AAU has an association with disease activity, functional ability and physical mobility in AS patients, 146 Chinese AS patients in Taiwan were enrolled in a cross-sectional study. These patients fulfilled the 1984 modified New York criteria and visited the Outpatient Department of the Veterans General Hospital-Taipei from April 2004 to July 2005. Patients completed questionnaires assessing disease activity [Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)], functional ability [Bath Ankylosing Spondylitis Functional Index (BASFI)] and patient's global assessment [Bath Ankylosing Spondylitis Patient Global Score (BAS-G)]. Meanwhile, physical examinations were performed, including Schober test, finger-to-floor, lateral spinal flexion, occiput-to-wall and chest expansion. The history of AAU was accepted only if diagnosed by an ophthalmologist. The prevalence of AAU in this Chinese AS cohort was 15.8% (23/146). Patients with AAU had a significantly higher BASDAI than those without [absolute differences=0.96, 95% confidence intervals (CI): 0.35-1.88]. Additionally, patients with AAU had significantly increased BASFI than those without (absolute differences=1.46, 95% CI: 0.33-2.59). Moreover, there was advanced limitation of physical motility in patients with AAU, including finger-to-floor, occiput-to-wall distances and Schober test, (95% CI: 3.89-16.95 and p=0.046, respectively). Disease duration mildly correlated with BASFI (r=0.24, p=0.003) but not with BASDAI (p=0.838). There was no difference of disease duration between patients with and without AAU (p=0.343). These results suggested that the presence of AAU in AS patients may be associated with higher disease activity, poor functional ability and advanced physical impairment.

Entities:  

Mesh:

Year:  2006        PMID: 17021671     DOI: 10.1007/s10067-006-0403-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  13 in total

1.  Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.

Authors:  Michael M Ward; Michael H Weisman; John C Davis; John D Reveille
Journal:  Arthritis Rheum       Date:  2005-10-15

2.  The outcome of ankylosing spondylitis: a study of 100 patients.

Authors:  J T Gran; J F Skomsvoll
Journal:  Br J Rheumatol       Date:  1997-07

3.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

4.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.

Authors:  E Jaakkola; I Herzberg; K Laiho; M C N M Barnardo; J J Pointon; M Kauppi; K Kaarela; E Tuomilehto-Wolf; J Tuomilehto; B P Wordsworth; M A Brown
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

Review 7.  Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.

Authors:  J Braun; X Baraliakos; J Listing; J Sieper
Journal:  Arthritis Rheum       Date:  2005-08

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Authors:  S Garrett; T Jenkinson; L G Kennedy; H Whitelock; P Gaisford; A Calin
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis.

Authors:  M A Khan; I Kushner; W E Braun
Journal:  Arthritis Rheum       Date:  1977-05
View more
  15 in total

Review 1.  Uveitis in seronegative arthritis.

Authors:  Daniel Wendling
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

2.  Radiological Quiz.

Authors:  U Rajesh; S Verma; K Satyanand
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders.

Authors:  Laura J Kopplin; George Mount; Eric B Suhler
Journal:  Ocul Immunol Inflamm       Date:  2016-05-27       Impact factor: 3.070

Review 4.  Ankylosing spondylitis: Chinese perspective, clinical phenotypes, and associated extra-articular systemic features.

Authors:  Huei-Huang Ho; Ji-Yih Chen
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

5.  Clinical features of ankylosing spondylitis associated with acute anterior uveitis in Chinese patients.

Authors:  Shu-Xing Ji; Xiao-Lei Yin; Rong-Di Yuan; Zheng Zheng; Yan Huo; Huan Zou
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

6.  Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.

Authors:  Simon M Stebbings; Gareth J Treharne; Katey Jenks; John Highton
Journal:  Clin Rheumatol       Date:  2013-12-10       Impact factor: 2.980

7.  Frequency and characteristics of disease flares in ankylosing spondylitis.

Authors:  Roxanne Cooksey; Sinead Brophy; Mike B Gravenor; Caroline J Brooks; Claire L Burrows; Stefan Siebert
Journal:  Rheumatology (Oxford)       Date:  2010-02-01       Impact factor: 7.580

Review 8.  Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.

Authors:  Claudia Fabiani; Antonio Vitale; Giuseppe Lopalco; Florenzo Iannone; Bruno Frediani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-09-30       Impact factor: 2.980

Review 9.  Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye.

Authors:  Muhammad A Khan; Muhammad Haroon; James T Rosenbaum
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

10.  Radiographic Progression in Patients With Ankylosing Spondylitis According to Uveitis Based on the Observation Study of Korean Spondyloarthropathy Registry.

Authors:  Hyunyi Kook; So-Hee Jin; Seunghun Lee; Seung-Jin Lee; Tae-Hwan Kim; Tae-Jong Kim
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.